Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | DNA polymerase delta catalytic subunit homolog | 0.0224 | 0.6641 | 1 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0118 | 0.2719 | 0.2463 |
Plasmodium vivax | DNA polymerase alpha, putative | 0.0104 | 0.2208 | 0.1675 |
Brugia malayi | DNA polymerase alpha catalytic subunit | 0.0104 | 0.2208 | 0.2964 |
Trypanosoma brucei | unspecified product | 0.0061 | 0.0604 | 0.0273 |
Plasmodium falciparum | DNA polymerase delta catalytic subunit | 0.0224 | 0.6641 | 1 |
Schistosoma mansoni | DNA polymerase alpha catalytic subunit | 0.0113 | 0.2523 | 0.226 |
Trypanosoma brucei | DNA polymerase epsilon catalytic subunit, putative | 0.008 | 0.1316 | 0.101 |
Echinococcus multilocularis | dna polymerase epsilon catalytic subunit a | 0.008 | 0.1316 | 0.1548 |
Onchocerca volvulus | DNA polymerase epsilon catalytic subunit A homolog | 0.008 | 0.1316 | 0.1548 |
Giardia lamblia | DNA polymerase delta, catalytic subunit | 0.0224 | 0.6641 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0132 | 0.3212 | 0.5 |
Echinococcus multilocularis | DNA polymerase zeta catalytic subunit | 0.008 | 0.1316 | 0.1548 |
Trypanosoma brucei | DNA polymerase delta catalytic subunit, putative | 0.0224 | 0.6641 | 0.6523 |
Treponema pallidum | ribonuclease H (rnhA) | 0.0054 | 0.034 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0132 | 0.3212 | 0.5 |
Trypanosoma cruzi | DNA polymerase delta catalytic subunit, putative | 0.018 | 0.5 | 0.6443 |
Brugia malayi | DNA polymerase family B, exonuclease domain containing protein | 0.008 | 0.1316 | 0.1548 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0118 | 0.2719 | 0.329 |
Leishmania major | DNA polymerase I alpha catalytic subunit, putative | 0.0087 | 0.1583 | 0.1719 |
Trichomonas vaginalis | ribonuclease H1, putative | 0.0054 | 0.034 | 0.0512 |
Trypanosoma cruzi | DNA polymerase epsilon catalytic subunit, putative | 0.008 | 0.1316 | 0.1349 |
Trypanosoma brucei | RNA helicase, putative | 0.0315 | 1 | 1 |
Trichomonas vaginalis | DNA polymerase alpha catalytic subunit, putative | 0.0087 | 0.1583 | 0.2384 |
Giardia lamblia | DNA polymerase epsilon, catalytic subunit | 0.008 | 0.1316 | 0.1548 |
Echinococcus granulosus | DNA polymerase delta catalytic subunit | 0.0224 | 0.6641 | 1 |
Trichomonas vaginalis | DNA polymerase alpha catalytic subunit, putative | 0.008 | 0.1316 | 0.1981 |
Trichomonas vaginalis | DNA polymerase delta catalytic subunit, putative | 0.008 | 0.1316 | 0.1981 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0061 | 0.0604 | 0.0273 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0061 | 0.0604 | 0.0273 |
Entamoeba histolytica | DNA polymerase delta catalytic subunit, putative | 0.0224 | 0.6641 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.0054 | 0.034 | 0.5 |
Schistosoma mansoni | DNA polymerase epsilon catalytic subunit | 0.008 | 0.1316 | 0.101 |
Onchocerca volvulus | DNA polymerase alpha catalytic subunit homolog | 0.013 | 0.3147 | 0.4455 |
Trypanosoma cruzi | DNA polymerase delta catalytic subunit, putative | 0.0224 | 0.6641 | 0.8712 |
Trichomonas vaginalis | DNA polymerase zeta catalytic subunit, putative | 0.0224 | 0.6641 | 1 |
Leishmania major | DNA polymerase epsilon catalytic subunit, putative | 0.008 | 0.1316 | 0.1349 |
Echinococcus granulosus | DNA polymerase zeta catalytic subunit | 0.008 | 0.1316 | 0.1548 |
Brugia malayi | DNA polymerase family B containing protein | 0.008 | 0.1316 | 0.1548 |
Toxoplasma gondii | DNA polymerase (pol2) superfamily protein | 0.0104 | 0.2208 | 0.2964 |
Trypanosoma cruzi | DNA polymerase epsilon catalytic subunit, putative | 0.008 | 0.1316 | 0.1349 |
Trypanosoma brucei | DNA polymerase zeta catalytic subunit, putative | 0.008 | 0.1316 | 0.101 |
Brugia malayi | DNA polymerase delta catalytic subunit | 0.0224 | 0.6641 | 1 |
Leishmania major | DNA polymerase delta catalytic subunit, putative | 0.0224 | 0.6641 | 0.8712 |
Schistosoma mansoni | DNA polymerase delta catalytic subunit | 0.0224 | 0.6641 | 0.6523 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0118 | 0.2719 | 0.329 |
Trypanosoma cruzi | DNA polymerase I alpha catalytic subunit, putative | 0.0087 | 0.1583 | 0.1719 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0061 | 0.0604 | 0.0273 |
Trichomonas vaginalis | DNA polymerase II, putative | 0.0087 | 0.1583 | 0.2384 |
Leishmania major | mitochondrial DNA polymerase beta | 0.025 | 0.7573 | 1 |
Onchocerca volvulus | DNA polymerase homolog | 0.008 | 0.1316 | 0.1548 |
Toxoplasma gondii | DNA polymerase family B protein | 0.008 | 0.1316 | 0.1548 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.025 | 0.7573 | 1 |
Trypanosoma brucei | DNA polymerase alpha catalytic subunit | 0.0087 | 0.1583 | 0.1287 |
Loa Loa (eye worm) | hypothetical protein | 0.013 | 0.3147 | 0.4739 |
Echinococcus granulosus | DNA polymerase alpha catalytic subunit | 0.0113 | 0.2523 | 0.3464 |
Giardia lamblia | DNA polymerase alpha subunit A | 0.0068 | 0.0881 | 0.0859 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0061 | 0.0604 | 0.0273 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.025 | 0.7573 | 0.7488 |
Echinococcus granulosus | dna polymerase epsilon catalytic subunit a | 0.008 | 0.1316 | 0.1548 |
Plasmodium vivax | DNA polymerase delta catalytic subunit, putative | 0.0224 | 0.6641 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.025 | 0.7573 | 1 |
Echinococcus multilocularis | DNA polymerase alpha catalytic subunit | 0.0113 | 0.2523 | 0.3464 |
Loa Loa (eye worm) | DNA-directed DNA polymerase III | 0.0224 | 0.6641 | 1 |
Schistosoma mansoni | DNA polymerase zeta catalytic subunit | 0.008 | 0.1316 | 0.101 |
Toxoplasma gondii | DNA polymerase | 0.0224 | 0.6641 | 1 |
Echinococcus multilocularis | DNA polymerase delta catalytic subunit | 0.0224 | 0.6641 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.